Status:
COMPLETED
Effects of Exergame in Patients at High Cardiovascular Risk.
Lead Sponsor:
Kyoung Im Cho
Conditions:
Aerobic Exercise
Cardiorespiratory Fitness
Eligibility:
FEMALE
50-80 years
Phase:
NA
Brief Summary
Background: Exergaming is thought to have a similar effect on cardiovascular (CV) responses as aerobic fitness activities. The aim of this study was to compare the cardiovascular effects of exergaming...
Detailed Description
Introduction Cardiovascular (CV) disease is a major cause of premature death and morbidity worldwide. It is widely known that age, sex, hypertension, dyslipidemia, diabetes, and smoking are the main r...
Eligibility Criteria
Inclusion
- Framingham CV disease 10-year risk score above 20%
- post-menopausal women
- no history of exercise
Exclusion
- resistant hypertension
- liver disease
- neurologic disorders
- malignant disease
- chronic obstructive pulmonary disease
- valvular heart disease
- musculoskeletal patients
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2018
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04042896
Start Date
April 1 2017
End Date
March 31 2018
Last Update
August 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kosin University Gospel Hospital
Busan, South Korea, 49267